Phio Pharmaceuticals Income Statement (2011-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Shares Outstanding (Entity) (Quarter)	0.13M	0.13M	0.13M	0.13M	0.13M	0.13M	0.13M	192.05M	0.26M	0.23M	0.51M	0.51M	0.96M	0.79M	4.78M	4.80M	5.78M	5.98M	11.62M	11.62M
Revenue & cost
Revenue (Quarter)
Operating items
Research & Development (Quarter)	2.67M	8.89M	1.59M	1.30M	2.51M	1.61M	2.13M	1.38M	1.81M	1.01M	1.15M	0.87M	0.64M	0.98M	0.89M	1.07M	1.18M		2.79M	3.08M
Selling, General & Administrative (Quarter)	1.07M	1.23M	1.05M	1.22M	1.06M	1.12M	1.47M	1.16M	0.97M	0.77M	1.06M	1.05M	0.95M	0.69M	0.99M	1.24M	1.32M		1.37M	1.19M
Restructuring Costs (Quarter)
Other Operating Expenses (Quarter)		-6.66M								0.13M
Operating Expenses (Quarter)	3.74M	3.45M	2.64M	2.52M	3.57M	2.73M	3.60M	2.55M	2.78M	1.90M	2.21M	1.91M	1.59M	1.67M	1.87M	2.31M	2.50M		4.17M	4.27M
Operating Income (Quarter)	-3.74M	-3.45M	-2.64M	-2.52M	-3.57M	-2.73M	-3.60M	-2.55M	-2.78M	-1.90M	-2.21M	-1.91M	-1.59M	-1.67M	-1.87M	-2.31M	-2.50M		-4.17M	-4.27M
EBIT (Quarter)	-3.74M	-3.45M	-2.64M	-2.52M	-3.57M	-2.73M	-3.60M	-2.55M	-2.78M	-1.90M	-2.21M	-1.91M	-1.59M	-1.67M	-1.87M	-2.31M	-2.50M		-4.17M	-4.27M
Non-operating items
Interest & Investment Income (Quarter)													0.07M	0.02M	0.12M		0.11M	0.08M	0.16M	0.13M
Other Non Operating Income (Quarter)		-1.56M													-0.02M				0.00M
Non Operating Income (Quarter)	-0.00M	-0.00M	-0.00M	-0.01M	-0.01M	-0.00M		-0.00M	-0.00M	0.00M	0.00M	0.07M	0.07M		-0.02M	0.14M
Net income details
EBT (Quarter)	-3.78M	-3.47M	-2.67M	-2.56M	-3.60M	-2.76M	-3.64M	-2.58M	-2.81M	-1.81M	-2.16M	-1.91M	-1.52M	-1.71M	-1.62M	-2.31M	-2.39M		-4.01M	-4.14M
Tax Provisions (Quarter)
Profit After Tax (Quarter)	-3.74M	-3.45M	-2.64M	-2.53M	-3.58M	-2.73M	-3.60M	-2.55M	-2.78M	-1.90M	-2.15M	-1.85M	-1.52M	-1.63M	-1.77M	-2.17M	-2.39M		-4.00M	-4.14M
Income from Continuing Operations (Quarter)	-3.78M	-3.47M	-2.67M	-2.56M	-3.60M	-2.76M	-3.64M	-2.58M	-2.81M	-1.81M	-2.16M	-1.91M	-1.52M	-1.71M	-1.62M	-2.31M	-2.39M		-4.01M	-4.14M
Consolidated Net Income (Quarter)	-3.78M	-3.47M	-2.67M	-2.56M	-3.60M	-2.76M	-3.64M	-2.58M	-2.81M	-1.81M	-2.16M	-1.91M	-1.52M	-1.71M	-1.62M	-2.31M	-2.39M		-4.01M	-4.14M
Income towards Parent Company (Quarter)	-3.78M	-3.47M	-2.67M	-2.56M	-3.60M	-2.76M	-3.64M	-2.58M	-2.81M	-1.81M	-2.16M	-1.91M	-1.52M	-1.71M	-1.62M	-2.31M	-2.39M		-4.01M	-4.14M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	-3.78M	-3.47M	-2.67M	-2.56M	-3.60M	-2.76M	-3.64M	-2.58M	-2.81M	-1.81M	-2.16M	-1.91M	-1.52M	-1.71M	-1.62M	-2.31M	-2.39M		-4.01M	-4.14M
Additional items
EPS (Basic) (Quarter)	-30.19	-29.23	-21.28	-20.20	-28.50	-21.89	-28.65	-0.01	-10.37	-7.80	-4.24	-3.75	-1.54	-2.18	-0.38	-0.48	-0.44		-0.34	-0.36
EPS (Diluted) (Quarter)	-30.19	-29.22	-21.28	-20.20	-28.50	-21.89	-28.65	-0.01	-10.37	-7.80	-4.24	-3.75	-1.54	-2.18	-0.38	-0.48	-0.50		-0.84	-0.86
Shares Outstanding (Quarter)	0.13M	0.12M	0.13M	0.13M	0.13M	0.13M	0.13M	192.05M	0.27M	0.23M	0.51M	0.51M	0.99M	0.79M	4.31M	4.79M	5.47M	5.98M	11.62M	11.62M
Shares Outstanding (Diluted) (Quarter)	0.13M	0.12M	0.13M	0.13M	0.13M	0.13M	0.13M	192.05M	0.27M	0.23M	0.51M	0.51M	0.99M	0.79M	4.31M	4.79M	4.79M	4.79M	4.79M	4.79M
EBITDA (Quarter)	-3.74M	-3.45M	-2.64M	-2.52M	-3.57M	-2.73M	-3.60M	-2.55M	-2.78M	-1.90M	-2.21M	-1.91M	-1.59M	-1.67M	-1.87M	-2.31M	-2.50M		-4.17M	-4.27M
Interest Expenses (Quarter)	0.04M	0.02M	0.03M	0.03M	0.03M	0.03M	0.03M	0.04M	0.04M	-0.09M	-0.05M	-0.00M		0.06M	-0.12M			2.61M
Tax Rate (Quarter)

Research Tools

Datasets

Plans

Developers

Phio Pharmaceuticals PHIO Income Statement (2011-2026)

Research Tools

Datasets

Plans

Developers

Phio Pharmaceuticals PHIO Income Statement (2011-2026)

Create an account

Sign In

Reset Password